These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16022851)

  • 1. Blood copper levels in Mexican users of the T380A IUD.
    De la Cruz D; Cruz A; Arteaga M; Castillo L; Tovalin H
    Contraception; 2005 Aug; 72(2):122-5. PubMed ID: 16022851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of leukaemia inhibitory factor (LIF) during the window of implantation in copper T380A intrauterine device users.
    Güney M; Oral B; Karahan N; Mungan T
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):212-9. PubMed ID: 17763259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum copper levels in users of multiload intra-uterine contraceptive devices.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1989 Dec; 18(4):295-9. PubMed ID: 2558561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in copper homeostasis and oxidative stress biomarkers in women using the intrauterine device TCu380A.
    Arnal N; de Alaniz MJ; Marra CA
    Toxicol Lett; 2010 Feb; 192(3):373-8. PubMed ID: 19931365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atomic absorption spectrophotometry study of copper ion release by copper-bearing intrauterine devices].
    Berthou J; Chrétien FC; Driguez PA
    Contracept Fertil Sex; 1998 Nov; 26(11):781-9. PubMed ID: 9864885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2004 Aug; 70(2):169-72. PubMed ID: 15288224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid function in lactating women using the Progestasert system.
    Ibrahim II; Abdalla MI; Badraoui MH; Abdelaal AE
    Contracept Deliv Syst; 1981 Apr; 2(1):139-44. PubMed ID: 12336866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the release behavior of cupric ion for three types of Cu-IUDs and indomethacin for medicated Cu-IUD in simulated uterine fluid.
    Jinying L; Ying L; Xuan G; Yanli G; Jianping L
    Contraception; 2008 Apr; 77(4):299-302. PubMed ID: 18342655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper IUD emission and its effects on human cervical mucus: spermatozoa interaction.
    Ros A; Piemonte G; Rugiati S
    Contracept Deliv Syst; 1980 Apr; 1(2):113-8. PubMed ID: 12336236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different contraceptive methods on the oxidative stress status in women aged 40 48 years from the ELAN study in the province of Liege, Belgium.
    Pincemail J; Vanbelle S; Gaspard U; Collette G; Haleng J; Cheramy-Bien JP; Charlier C; Chapelle JP; Giet D; Albert A; Limet R; Defraigne JO
    Hum Reprod; 2007 Aug; 22(8):2335-43. PubMed ID: 17584753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the complications of 2 copper intrauterine devices: T380A and Cu-Safe 300.
    Nahidi F; Jalalinia S
    East Mediterr Health J; 2008; 14(1):95-102. PubMed ID: 18557456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc depletion and menorrhagia in Nigerians using copper T-200 intrauterine device.
    Wright EA; Kapu MM; Isichei UP
    Trace Elem Med; 1989; 6(4):147-9. PubMed ID: 12343060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antifertility effectiveness of a novel copper-containing composite used in intrauterine contraceptive devices and the releasing behavior of cupric ions contained in the composite in rats.
    Peng X; Hu S; Meng T; Suo J; Xiong C
    Contraception; 2012 Oct; 86(4):413-8. PubMed ID: 22445435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochrane systematic reviews of IUD trials: lessons learned.
    Grimes DA; Lopez LM; Manion C; Schulz KF
    Contraception; 2007 Jun; 75(6 Suppl):S55-9. PubMed ID: 17531618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of allergy to a copper-medicated IUD. Etiopathogenetic and clinical aspects].
    Pacilli L; Graffino W; Poggio A; Arrotta S
    Minerva Ginecol; 1981 Dec; 33(12):1159-63. PubMed ID: 6460950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen.
    Hubacher D; Reyes V; Lillo S; Pierre-Louis B; Zepeda A; Chen PL; Croxatto H
    Hum Reprod; 2006 Jun; 21(6):1467-72. PubMed ID: 16484309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of long-term installation of intrauterine devices on intrauterine microenvironment].
    Dong BH; Hou GH; Zhang YZ; Fan J; Zhang P; Li L; Luo X
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):823-6. PubMed ID: 12895331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplasia with use of intrauterine devices.
    Curtis KM; Marchbanks PA; Peterson HB
    Contraception; 2007 Jun; 75(6 Suppl):S60-9. PubMed ID: 17531619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.